Robin Foà
About
Robin Foà is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine.
According to data from OpenAlex, Robin Foà has authored 501 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 233 papers in Genetics, 229 papers in Hematology and 145 papers in Pathology and Forensic Medicine. Recurrent topics in Robin Foà's work include Chronic Lymphocytic Leukemia Research (212 papers), Lymphoma Diagnosis and Treatment (138 papers) and Acute Lymphoblastic Leukemia research (137 papers). Robin Foà is often cited by papers focused on Chronic Lymphocytic Leukemia Research (212 papers), Lymphoma Diagnosis and Treatment (138 papers) and Acute Lymphoblastic Leukemia research (137 papers). Robin Foà collaborates with scholars based in Italy, United States and France. Robin Foà's co-authors include Sabina Chiaretti, Anna Guarini, Antonella Vitale, Gianluca Gaïdano, Marco Vignetti, Franco Mandelli, Anna Guarini, Loredana Elia, Francesca Romana Mauro and Robert Knight and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
Robin Foà
483 papers receiving 14.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Robin Foà Italy | 57 | 5.7k | 5.0k | 4.5k | 4.4k | 3.8k | 501 | 14.9k | ||
| Carlos E. Bueso‐Ramos United States | 59 | 6.0k 1.1× | 5.8k 1.2× | 3.0k 0.7× | 4.3k 1.0× | 2.3k 0.6× | 386 | 14.7k | ||
| Marcos González Spain | 62 | 8.1k 1.4× | 5.3k 1.1× | 2.9k 0.7× | 4.1k 0.9× | 2.5k 0.7× | 376 | 14.1k | ||
| David C. Linch United Kingdom | 74 | 8.9k 1.6× | 4.8k 1.0× | 7.0k 1.5× | 4.9k 1.1× | 3.7k 1.0× | 358 | 20.9k | ||
| Maher Albitar United States | 65 | 9.2k 1.6× | 7.5k 1.5× | 4.5k 1.0× | 8.2k 1.8× | 3.4k 0.9× | 342 | 20.0k | ||
| Alessandra Ferrajoli United States | 69 | 7.4k 1.3× | 4.1k 0.8× | 3.1k 0.7× | 9.3k 2.1× | 3.6k 1.0× | 527 | 16.4k | ||
| Richard J. Jones United States | 66 | 7.8k 1.4× | 3.3k 0.7× | 4.3k 1.0× | 2.4k 0.5× | 3.8k 1.0× | 333 | 14.4k | ||
| Dieter Hoelzer Germany | 62 | 7.3k 1.3× | 4.6k 0.9× | 4.6k 1.0× | 4.6k 1.0× | 1.9k 0.5× | 322 | 16.5k | ||
| Charles Koller United States | 65 | 6.8k 1.2× | 3.6k 0.7× | 3.0k 0.7× | 7.5k 1.7× | 3.3k 0.9× | 239 | 15.1k | ||
| Edo Vellenga Netherlands | 72 | 8.7k 1.5× | 7.6k 1.5× | 5.3k 1.2× | 2.7k 0.6× | 3.4k 0.9× | 487 | 18.7k | ||
| Andrew W. Roberts Australia | 67 | 5.5k 1.0× | 7.6k 1.5× | 5.0k 1.1× | 4.9k 1.1× | 4.7k 1.2× | 275 | 17.4k |
Countries citing papers authored by Robin Foà
Since
Specialization
Citations
This map shows the geographic impact of Robin Foà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Foà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Foà more than expected).
Fields of papers citing papers by Robin Foà
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Robin Foà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Foà. The network helps show where Robin Foà may publish in the future.
Co-authorship network of co-authors of Robin Foà
This figure shows the co-authorship network connecting the top 25 collaborators of Robin Foà. A scholar is included among the top collaborators of Robin Foà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Foà. Robin Foà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Gökbuget, Nicola, Nicolas Boissel, Sabina Chiaretti, et al.. (2024). Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood. 143(19). 1903–1930.
2.
Natoni, Alessandro, Maria Stefania De Propris, Maria Teresa Petrucci, et al.. (2023). Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity. Cancers. 15(7). 2154–2154.
3.
Starza, Irene Della, Lucia Anna De Novi, Loredana Elia, et al.. (2023). Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia. Cancers. 15(2). 374–374.
4.
Ranieri, Sofia Chiatamone, et al.. (2019). Aplastic Anemia and Good Syndrome in a Heavily Treated Stage IV Thymoma Patient: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2019. 1–6.
5.
Bosch, Francesc, Guy Cantin, Agostino Cortelezzi, et al.. (2019). Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study. Leukemia. 34(2). 441–450.
6.
Hijiya, Nobuko, C. Michel Zwaan, Carmelo Rizzari, et al.. (2019). Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome–Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia. Clinical Cancer Research. 26(4). 812–820.
7.
Carmosino, Ida, Massimo Breccia, Sara Mohamed, et al.. (2019). Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib. Oncology Research and Treatment. 42(12). 660–664.
8.
Nilsson, Malin S., Karin Christenson, Ebru Aydin, et al.. (2018). Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia. Cancer Immunology Research. 6(9). 1110–1119.
9.
Rossi, Davide, Fary Diop, Elisa Spaccarotella, et al.. (2017). Diffuse large B-cell lymphoma genotyping on the liquid biopsy. Blood. 129(14). 1947–1957.
10.
Rossi, Davide, Hossein Khiabanian, Valeria Spina, et al.. (2014). Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. Blood. 123(14). 2139–2147.
11.
Moschella, Federica, G Torelli, Mara Valentini, et al.. (2013). Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy. Clinical Cancer Research. 19(15). 4249–4261.
12.
Martinelli, Giovanni, Ilaria Iacobucci, Clelia Tiziana Storlazzi, et al.. (2009). IKZF1 (Ikaros) Deletions in BCR-ABL1 –Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report. Journal of Clinical Oncology. 27(31). 5202–5207.
13.
Fulci, Valerio, Teresa Colombo, Sabina Chiaretti, et al.. (2009). Characterization of B‐ and T‐lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Genes Chromosomes and Cancer. 48(12). 1069–1082.
14.
Martini, Maurizio, Luciana Teofili, Tonia Cenci, et al.. (2008). A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis. Haematologica. 93(7). 1068–1071.
15.
Chiaretti, Sabina, Xiaochun Li, Robert Gentleman, et al.. (2005). Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation. Clinical Cancer Research. 11(20). 7209–7219.
16.
Annibali, Ombretta, Maria Teresa Petrucci, Maria Cristina Tirindelli, et al.. (2004). Treatment of 72 newly diagnosed Waldenström macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone. Cancer. 103(3). 582–587.
17.
Foà, Robin & Antonella Vitale. (2002). Towards an integrated classification of adult acute lymphoblastic leukemia. PubMed. 6(2). 181–199.
18.
Revoltella, Roberto P., Anna Marina Liberati, Gigliola Reato, et al.. (2000). Antibodies Binding Granulocyte–Macrophage Colony Stimulating Factor Produced by Cord Blood-Derived B Cell Lines Immortalized by Epstein–Barr Virus in Vitro. Cellular Immunology. 204(2). 114–127.
19.
Foà, Robin, Maria Teresa Fierro, Margherita Bonferroni, et al.. (1990). Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin. British Journal of Haematology. 75(1). 34–40.
20.
Catovsky, Daniel, Sally M. Pittman, Maureen M. O’Brien, et al.. (1979). Multiparameter studies in lymphoid leukemias.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(4 Suppl). 736–45.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Carlos E. Bueso‐Ramos Breakdown of academic impact, for papers by Marcos González Breakdown of academic impact, for papers by David C. Linch Breakdown of academic impact, for papers by Maher Albitar Breakdown of academic impact, for papers by Alessandra Ferrajoli Breakdown of academic impact, for papers by Richard J. Jones Breakdown of academic impact, for papers by Dieter Hoelzer Breakdown of academic impact, for papers by Charles Koller Breakdown of academic impact, for papers by Edo Vellenga Breakdown of academic impact, for papers by Andrew W. Roberts